Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
NA
Total Enrollment
45 participants
Study Classification
INTERVENTIONAL
Study Start Date
2018-05-01
Study Completion Date
2019-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To understand the effects of a novel dietary supplement when used in conjunction with a healthy lifestyle exercise program and to define biomarkers that are specific to sarcopenia. A primary aim in the present study is to determine whether a relationship exists between positive changes in body composition through increases in lean mass and reductions in body fat following oral supplementation of naturally occurring food components in combination with exercise. The purpose of the present study is to examine the effects of a multi-nutrient supplement in combination with an endurance and resistance based exercise intervention in a cohort of older adult men with varying degrees of sarcopenia as compared to younger male controls (McMaster/CIHR/Exerkine project). A sub-purpose nested within the study is to provide serum and muscle samples for use in an aging/sarcopenia biomarker discovery study taken at pre-intervention for the young and older men (Buck Institute/Astellas project).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combining Nutrition Supplementation With an Exercise Program in Elderly Malnourished Frail Patients After Hospital Stay
NCT05325697
Frailty
Sarcopenia
Malnutrition; Protein
UNKNOWN
NA
Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults
NCT06231069
Sarcopenia
WITHDRAWN
NA
Dietary Supplements and Exercise in Aging Adults
NCT00761553
Exercise
COMPLETED
NA
Effectiveness of Creatine Supplementation and Exercise on Muscle and Bone
NCT01057680
Osteoporosis
Sarcopenia
COMPLETED
PHASE3
Exercise and Nutrition for Healthy AgeiNg
NCT03649698
Sarcopenia
RECRUITING
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The present study is a randomized double-blind placebo controlled repeated measures design, with sampling of the cohorts on multiple occasions. Upon obtaining informed consent participants will be randomized into one of six groups:
Healthy younger males - n=20; Healthy older males - placebo n=10, supplement n=10; Sarcopenic older males, placebo, n=20, supplement n=20;
Take home resistance training program The older adult male groups will be provided with a progressive resistance training program which will use exercise bands (Therabands®, Akron, Ohio) and consist of six upper body and six lower body exercises, which will be performed three times per week for 12 weeks without supervision at home. Each session will consist of active warm-up (5min), resistance training with elastic tubing (45min), and cool down (5min). Briefly, the resistance exercises will be performed using elastic tubing for chair squats, hip flexions, leg extensions, leg flexions, ankle dorsiflexion, wall push-ups, back rows, shoulder abductions, triceps extensions, and forearm flexions. Ankle plantar-flexions and abdominal curl-ups will be performed using body weight as resistance. Each participant will be given an exercise instruction booklet and a set of five elastic tubes offering different resistances. Prior to beginning the program trained staff will meet with participants and will teach them how to properly perform exercises in addition to determining the starting elastic tubing size. Furthermore, participants will perform one set of each exercise during weeks 1 and 2, two sets of each exercise during weeks 3 and 4, and three sets of lower body and two sets of upper body exercises during the remaining weeks. Participants will be instructed to move to the next larger tubing size when they can perform 12 repetitions with good exercise form during their last set. This progression will be monitored by the project staff mid way through the study over the phone.
Study products Study products will be provided by Infinit Nutrition Canada (Windsor, Ontario) to all older male subjects, however the young males will only act as baseline controls. The composition of the study products is displayed above in the general experimental design. Both products are similar in taste and appearance and provide an energetic value of ∼200 kcal per serving in a volume of 200 mL. Participants will be asked to consume 1 serving daily of the study product throughout the 12-wk intervention period. Participants will consume their serving at approximately the same time of day, but preferably before breakfast. Participants will be instructed to consume the supplement as a single bolus within 5-10 min. Subjects will also also be provided an omega-3 supplement (or placebo, if they are assigned to the placebo arm) and be instructed to consume 2 teaspoons at the same time as their nutritional supplement. Participants will be instructed to record product intake in a diary to check compliance. To maintain the double-blind nature of the experiment, the placebos, which contains microcrystalline cellulose or safflower oil, will be matched in size and appearance.
Three day weighed food record Participants will be asked to record everything that they consumed for 3 nonconsecutive days: 2 week-days and either a Saturday or a Sunday. On completion of the food record, it will be analyzed using a commercially available computerized database software (Nutribase version 11.5, Cybersoft Inc., Phoenix, AZ, USA). Food items will be aggregated into the following categories: fruit (e.g., fresh/frozen, tinned, juice), vegetables (e.g., fresh/frozen, canned), dairy products (e.g., milk, yoghurt, cheese), breads and cereals (e.g., bread, breakfast cereal, rice, pasta), meats and alternatives (e.g., red meat, poultry, fish, pork, processed meat, tofu, eggs, nuts) and extra foods (e.g., hamburger, pizza, meat pies, chocolate, cake, ice cream, jam, biscuits, crackers, crisps, alcohol).
Pedometer Participants will be given a wearable activity tracker, and instructed on weight training days to aim for 5,000 steps and on all other days to try and reach 10,000. All participants will record their daily totals for subsequent analysis.
Dual X-ray absorptiometry (DXA) and blood pressure A DXA scan is a non-invasive procedure requiring the participant to only lay still on a padded table. It is a fast procedure that provides a variety of body composition variables (bone mass/area/density, fat mass, and fat free mass). The DXA scan exposes individuals to low levels of radiation, approximately 0.18 millirem. According to the United States Nuclear Regulatory Commission, Americans receive approximately 620 millirem each year, half of which is due to environmental background radiation. Radiation exposure can be due to medical treatments or procedures, like X-Ray or MRI's, food, sun exposure, etc. Any exposure to radiation can increase the risk of cancer. In the present study, body composition will be assessed using DXA scan (GE Lunar Prodigy, Madison, WI) and a software program for adults (encore Version 9.15.010). Fat free mass (FFM), fat mass (FM) and bone mineral density (BMD) of the entire body will be recorded. Arterial blood pressure (i.e., systolic \[SBP\] and diastolic \[DBP\]) will be measured during rest with a stethoscope (Marshall Nurse Stethoscope, Riverside, Ill., USA) and sphygmomanometer (MDF Instruments Direct Inc., Agoura Hills, Calif., USA).
Muscle biopsies Participants will arrive in the morning in the fasted state and rest quietly in the supine position for 10 minutes. A muscle biopsy will then be taken from the vastus lateralis using local anaesthetic. Samples will be dissected free of connective tissue and immediately partitioned for subsequent analysis (\~ 25 mg) for RNA, a small piece (\~ 10 mg) will be placed into chilled glutaraldehyde for subsequent electron microscopic evaluation, \~ 20 mg will be frozen for mtDNA deletions, and \~ 50 mg will be frozen for enzyme and protein analysis. The investigators will measure muscle anabolic signaling as previously reported.
Blood sampling A total of 100 mL blood will be taken from the antecubital vein and drawn into evacuated tubes with heparin used for plasma collection and non-treated tubes will be used to collect serum.
Waist and hip circumference measures For waist circumference measurement, the participant will stand with arms at the sides, feet together, and abdomen relaxed. Using a Gulick tape measure, a horizontal measure will be taken at the narrowest part of the torso (above the umbilicus and below the xiphoid process). Obtaining a horizontal measure directly above the iliac crest enhances standardization according to The National Obesity Task Force. For hip circumference measurement, the participant stands erect and feet together, a horizontal measure is taken at the maximal circumference of buttocks.
Physical performance battery A total of four functional tasks will be performed once using a stopwatch that records times to an accuracy 1/100 of a second. First, the 6-minute walk test will involve participants walking as fast as possible around a 20m track for 6 minutes and distance will be measured to the closest meter. Next, the standard 4-stair climb test will involve participants climbing 4 stairs as fast as possible. A 5x sit-to-stand test will involve participants performing a series of consecutive rising and sitting positions from a sturdy, armless plastic chair secured against a wall and with arms crossed at the chest. Finally, the chair rise-and-walk test will involve participants starting from a seated position, standing up and walking as quickly as possible in a predetermined straight line to a pylon 9.14m, while going around the pylon, and returning to their original seated position.
Leg press 1RM Assessment procedures for determining lower body strength using leg press exercise equipment (Cybex Eagle ®, Medway, MA) will require the participant to sit in the leg press machine with the right foot and left foot on the weight platform. The seat and back pad will be adjusted so that feet are flat on the platform hip-width apart, toes slightly angled out, and legs parallel to each other. The interviewer will then instruct the participant to grasp the handles or sides of the seat and extend their legs leaving just a slight bend in the knee. Next, the participant will remove the racking mechanism from the platform and grasp the handles or seat again. The participant will begin with a selected weight that is within their perceived ability, approximately 60 to 80% of maximum capacity (make an educated guess). The participant will lower the platform slowly and controlled towards the chest, keeping the hips and buttocks on the seat, and the back flat against the back pad. Once the thighs are parallel to the platform the participant will extend the legs, pushing the weight back to the start position as hard and as fast as possible. The participant will be instructed to not allow their hips to shift to one side, the buttocks to rise, or knees to move inward or outward during this exercise. The interviewer will also instruct the participant to keep heels flat and not allow the knees to go beyond the toes. Once the repetitions are completed, the participant will replace the racking mechanism and exit the leg press. These procedures were adapted from procedures described by the National Strength and Condition Association (2008) and the American College of Sports Medicine (2013).
Hand grip strength (MVIC) Hand grip strength will be measured using an isometric dynamometer (JAMAR®, Sammons, Bolingbrook, IL). The grip width will be adjusted to hand size and with arm flexed at 90°, the participant will perform three X 5 s efforts with a one min rest between trials.
Knee extension (MVIC) Isometric knee extension will be measured by mechanical dynamometry (Biodex System 3, Biodex Medical Systems, Shirley, NY). Participants will be positioned into the machine with the knee flexed at 90° and perform three X 5s maximal voluntary contractions with 30s rest between each trial.
SF-36 Quality of health Questionnaire The RAND 36-Item Health Survey (Version 1.0) taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health.
Healthy younger males - n=20; Healthy older males - placebo n=10, supplement n=10; Sarcopenic older males, placebo, n=20, supplement n=20;
Take home resistance training program The older adult male groups will be provided with a progressive resistance training program which will use exercise bands (Therabands®, Akron, Ohio) and consist of six upper body and six lower body exercises, which will be performed three times per week for 12 weeks without supervision at home. Each session will consist of active warm-up (5min), resistance training with elastic tubing (45min), and cool down (5min). Briefly, the resistance exercises will be performed using elastic tubing for chair squats, hip flexions, leg extensions, leg flexions, ankle dorsiflexion, wall push-ups, back rows, shoulder abductions, triceps extensions, and forearm flexions. Ankle plantar-flexions and abdominal curl-ups will be performed using body weight as resistance. Each participant will be given an exercise instruction booklet and a set of five elastic tubes offering different resistances. Prior to beginning the program trained staff will meet with participants and will teach them how to properly perform exercises in addition to determining the starting elastic tubing size. Furthermore, participants will perform one set of each exercise during weeks 1 and 2, two sets of each exercise during weeks 3 and 4, and three sets of lower body and two sets of upper body exercises during the remaining weeks. Participants will be instructed to move to the next larger tubing size when they can perform 12 repetitions with good exercise form during their last set. This progression will be monitored by the project staff mid way through the study over the phone.
Study products Study products will be provided by Infinit Nutrition Canada (Windsor, Ontario) to all older male subjects, however the young males will only act as baseline controls. The composition of the study products is displayed above in the general experimental design. Both products are similar in taste and appearance and provide an energetic value of ∼200 kcal per serving in a volume of 200 mL. Participants will be asked to consume 1 serving daily of the study product throughout the 12-wk intervention period. Participants will consume their serving at approximately the same time of day, but preferably before breakfast. Participants will be instructed to consume the supplement as a single bolus within 5-10 min. Subjects will also also be provided an omega-3 supplement (or placebo, if they are assigned to the placebo arm) and be instructed to consume 2 teaspoons at the same time as their nutritional supplement. Participants will be instructed to record product intake in a diary to check compliance. To maintain the double-blind nature of the experiment, the placebos, which contains microcrystalline cellulose or safflower oil, will be matched in size and appearance.
Three day weighed food record Participants will be asked to record everything that they consumed for 3 nonconsecutive days: 2 week-days and either a Saturday or a Sunday. On completion of the food record, it will be analyzed using a commercially available computerized database software (Nutribase version 11.5, Cybersoft Inc., Phoenix, AZ, USA). Food items will be aggregated into the following categories: fruit (e.g., fresh/frozen, tinned, juice), vegetables (e.g., fresh/frozen, canned), dairy products (e.g., milk, yoghurt, cheese), breads and cereals (e.g., bread, breakfast cereal, rice, pasta), meats and alternatives (e.g., red meat, poultry, fish, pork, processed meat, tofu, eggs, nuts) and extra foods (e.g., hamburger, pizza, meat pies, chocolate, cake, ice cream, jam, biscuits, crackers, crisps, alcohol).
Pedometer Participants will be given a wearable activity tracker, and instructed on weight training days to aim for 5,000 steps and on all other days to try and reach 10,000. All participants will record their daily totals for subsequent analysis.
Dual X-ray absorptiometry (DXA) and blood pressure A DXA scan is a non-invasive procedure requiring the participant to only lay still on a padded table. It is a fast procedure that provides a variety of body composition variables (bone mass/area/density, fat mass, and fat free mass). The DXA scan exposes individuals to low levels of radiation, approximately 0.18 millirem. According to the United States Nuclear Regulatory Commission, Americans receive approximately 620 millirem each year, half of which is due to environmental background radiation. Radiation exposure can be due to medical treatments or procedures, like X-Ray or MRI's, food, sun exposure, etc. Any exposure to radiation can increase the risk of cancer. In the present study, body composition will be assessed using DXA scan (GE Lunar Prodigy, Madison, WI) and a software program for adults (encore Version 9.15.010). Fat free mass (FFM), fat mass (FM) and bone mineral density (BMD) of the entire body will be recorded. Arterial blood pressure (i.e., systolic \[SBP\] and diastolic \[DBP\]) will be measured during rest with a stethoscope (Marshall Nurse Stethoscope, Riverside, Ill., USA) and sphygmomanometer (MDF Instruments Direct Inc., Agoura Hills, Calif., USA).
Muscle biopsies Participants will arrive in the morning in the fasted state and rest quietly in the supine position for 10 minutes. A muscle biopsy will then be taken from the vastus lateralis using local anaesthetic. Samples will be dissected free of connective tissue and immediately partitioned for subsequent analysis (\~ 25 mg) for RNA, a small piece (\~ 10 mg) will be placed into chilled glutaraldehyde for subsequent electron microscopic evaluation, \~ 20 mg will be frozen for mtDNA deletions, and \~ 50 mg will be frozen for enzyme and protein analysis. The investigators will measure muscle anabolic signaling as previously reported.
Blood sampling A total of 100 mL blood will be taken from the antecubital vein and drawn into evacuated tubes with heparin used for plasma collection and non-treated tubes will be used to collect serum.
Waist and hip circumference measures For waist circumference measurement, the participant will stand with arms at the sides, feet together, and abdomen relaxed. Using a Gulick tape measure, a horizontal measure will be taken at the narrowest part of the torso (above the umbilicus and below the xiphoid process). Obtaining a horizontal measure directly above the iliac crest enhances standardization according to The National Obesity Task Force. For hip circumference measurement, the participant stands erect and feet together, a horizontal measure is taken at the maximal circumference of buttocks.
Physical performance battery A total of four functional tasks will be performed once using a stopwatch that records times to an accuracy 1/100 of a second. First, the 6-minute walk test will involve participants walking as fast as possible around a 20m track for 6 minutes and distance will be measured to the closest meter. Next, the standard 4-stair climb test will involve participants climbing 4 stairs as fast as possible. A 5x sit-to-stand test will involve participants performing a series of consecutive rising and sitting positions from a sturdy, armless plastic chair secured against a wall and with arms crossed at the chest. Finally, the chair rise-and-walk test will involve participants starting from a seated position, standing up and walking as quickly as possible in a predetermined straight line to a pylon 9.14m, while going around the pylon, and returning to their original seated position.
Leg press 1RM Assessment procedures for determining lower body strength using leg press exercise equipment (Cybex Eagle ®, Medway, MA) will require the participant to sit in the leg press machine with the right foot and left foot on the weight platform. The seat and back pad will be adjusted so that feet are flat on the platform hip-width apart, toes slightly angled out, and legs parallel to each other. The interviewer will then instruct the participant to grasp the handles or sides of the seat and extend their legs leaving just a slight bend in the knee. Next, the participant will remove the racking mechanism from the platform and grasp the handles or seat again. The participant will begin with a selected weight that is within their perceived ability, approximately 60 to 80% of maximum capacity (make an educated guess). The participant will lower the platform slowly and controlled towards the chest, keeping the hips and buttocks on the seat, and the back flat against the back pad. Once the thighs are parallel to the platform the participant will extend the legs, pushing the weight back to the start position as hard and as fast as possible. The participant will be instructed to not allow their hips to shift to one side, the buttocks to rise, or knees to move inward or outward during this exercise. The interviewer will also instruct the participant to keep heels flat and not allow the knees to go beyond the toes. Once the repetitions are completed, the participant will replace the racking mechanism and exit the leg press. These procedures were adapted from procedures described by the National Strength and Condition Association (2008) and the American College of Sports Medicine (2013).
Hand grip strength (MVIC) Hand grip strength will be measured using an isometric dynamometer (JAMAR®, Sammons, Bolingbrook, IL). The grip width will be adjusted to hand size and with arm flexed at 90°, the participant will perform three X 5 s efforts with a one min rest between trials.
Knee extension (MVIC) Isometric knee extension will be measured by mechanical dynamometry (Biodex System 3, Biodex Medical Systems, Shirley, NY). Participants will be positioned into the machine with the knee flexed at 90° and perform three X 5s maximal voluntary contractions with 30s rest between each trial.
SF-36 Quality of health Questionnaire The RAND 36-Item Health Survey (Version 1.0) taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Sarcopenia
Healthy Elderly
Healthy Young
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Primary Study Purpose
TREATMENT
Blinding Strategy
QUADRUPLE
Participants
Caregivers
Investigators
Outcome Assessors
The nutritional supplement will be delivered to a 3rd party contract research organization and the allocation will only be un-blinded after data lock.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multinutrient Supplement
Participants will be allocated in a randomized double-masked manner to receive a multi-nutrient supplement (protein and creatine sachet and omega-3 oil) or placebo during a 12 week home-based exercise program and we will assess the influence on the primary and secondary outcomes.
Group Type
ACTIVE_COMPARATOR
multi-nutrient supplement
Intervention Type
DIETARY_SUPPLEMENT
Compare the effects of a multi-nutrient supplement following a healthy lifestyles program in healthy young men and women, healthy older men, and sarcopenic older men.
Age biological and chronological
The primary and secondary outcomes will be compared between the younger and older age groups as a function of both exercise and nutritional supplementation.
Group Type
NO_INTERVENTION
No interventions assigned to this group
Sarcopenia grades
The baseline primary and secondary outcomes will be compared for each of the 3 older adults males groups as a function of muscle mass (healthy active, mild sarcopenia and moderate sarcopenia).
Group Type
NO_INTERVENTION
No interventions assigned to this group
Exercise - home based programme
Each of the older participants will undergo a 12 week home-based exercise program (endurance = increased steps; resistance = body weight and elastic band exercise) to determine the effects on the primary and secondary outcomes.
Group Type
EXPERIMENTAL
Exercise
Intervention Type
OTHER
We will evaluate the effect of 12 weeks of combined endurance and resistance home-based exercise in younger and older adults.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
multi-nutrient supplement
Compare the effects of a multi-nutrient supplement following a healthy lifestyles program in healthy young men and women, healthy older men, and sarcopenic older men.
Intervention Type
DIETARY_SUPPLEMENT
Exercise
We will evaluate the effect of 12 weeks of combined endurance and resistance home-based exercise in younger and older adults.
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Inactive younger men (\< 1 hour of formal exercise/week) in the overweight BMI category (25 - 29.9 kg/m2).
* Healthy older male participants will have a body mass index \< 30 kg/m2, muscle mass index \> 7.23 kg/m2, and a 4-meter walk test \> 0.8 m/s.
* Men in the older adult "sarcopenia" group will be individuals that have a body mass index \< 30 kg/m2, a muscle mass index between 8.51-10.75 kg/m2, and a 4-meter walk test \< 0.8m/s.
* Healthy older male participants will have a body mass index \< 30 kg/m2, muscle mass index \> 7.23 kg/m2, and a 4-meter walk test \> 0.8 m/s.
* Men in the older adult "sarcopenia" group will be individuals that have a body mass index \< 30 kg/m2, a muscle mass index between 8.51-10.75 kg/m2, and a 4-meter walk test \< 0.8m/s.
Exclusion Criteria
* Current smokers
* On more than one anti-diabetic drug
* Cardiovascular disease (myocardial infarction and/or hypertension requiring more than 2 medications)
* Congestive heart failure
* Renal disease (creatinine \> 130)
* Previous stroke
* Hypertension requiring more than two-pharmacological agents
* Active musculoskeletal injuries and/or severe osteoarthritis
* Significant weight loss in the 3-month period prior to the study
* Vegan diet
* Dairy protein allergy
* History of muscle and/or bone wasting diseases
* Concurrent medications known to affect protein metabolism (i.e. corticosteroids, or prescription strength acne medications)
* Inability to consent
* Chronic obstructive pulmonary disease (FVC or FEV1 \< 80% of age predicted mean value or requiring any medication other than a puffer as needed)
* Concurrent supplementation with a dietary protein, calcium, l-leucine, creatine, CoQ10, alpha lipoic acid, n-3 PUFA, and conjugated linoleic acid.
* On more than one anti-diabetic drug
* Cardiovascular disease (myocardial infarction and/or hypertension requiring more than 2 medications)
* Congestive heart failure
* Renal disease (creatinine \> 130)
* Previous stroke
* Hypertension requiring more than two-pharmacological agents
* Active musculoskeletal injuries and/or severe osteoarthritis
* Significant weight loss in the 3-month period prior to the study
* Vegan diet
* Dairy protein allergy
* History of muscle and/or bone wasting diseases
* Concurrent medications known to affect protein metabolism (i.e. corticosteroids, or prescription strength acne medications)
* Inability to consent
* Chronic obstructive pulmonary disease (FVC or FEV1 \< 80% of age predicted mean value or requiring any medication other than a puffer as needed)
* Concurrent supplementation with a dietary protein, calcium, l-leucine, creatine, CoQ10, alpha lipoic acid, n-3 PUFA, and conjugated linoleic acid.
Minimum Eligible Age
18 Years
Maximum Eligible Age
85 Years
Eligible Sex
MALE
Accepts Healthy Volunteers
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McMaster University
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark Tarnopolsky
Principal Investigator, Professor, Director of Neuromuscular and Neurometabolic Clinic
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Tarnopololsky, MD/PhD
Role: PRINCIPAL_INVESTIGATOR
McMaster University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McMaster University Medical Center
Hamilton, Ontario, Canada
Site Status
Countries
Review the countries where the study has at least one active or historical site.
Canada
References
Explore related publications, articles, or registry entries linked to this study.
Brose A, Parise G, Tarnopolsky MA. Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. J Gerontol A Biol Sci Med Sci. 2003 Jan;58(1):11-9. doi: 10.1093/gerona/58.1.b11.
Reference Type
RESULT
Tarnopolsky M, Zimmer A, Paikin J, Safdar A, Aboud A, Pearce E, Roy B, Doherty T. Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults. PLoS One. 2007 Oct 3;2(10):e991. doi: 10.1371/journal.pone.0000991.
Reference Type
RESULT
Bell KE, Snijders T, Zulyniak M, Kumbhare D, Parise G, Chabowski A, Phillips SM. A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial. PLoS One. 2017 Jul 18;12(7):e0181387. doi: 10.1371/journal.pone.0181387. eCollection 2017.
Reference Type
RESULT
Murphy CH, Saddler NI, Devries MC, McGlory C, Baker SK, Phillips SM. Leucine supplementation enhances integrative myofibrillar protein synthesis in free-living older men consuming lower- and higher-protein diets: a parallel-group crossover study. Am J Clin Nutr. 2016 Dec;104(6):1594-1606. doi: 10.3945/ajcn.116.136424. Epub 2016 Nov 9.
Reference Type
RESULT
Churchward-Venne TA, Breen L, Di Donato DM, Hector AJ, Mitchell CJ, Moore DR, Stellingwerff T, Breuille D, Offord EA, Baker SK, Phillips SM. Leucine supplementation of a low-protein mixed macronutrient beverage enhances myofibrillar protein synthesis in young men: a double-blind, randomized trial. Am J Clin Nutr. 2014 Feb;99(2):276-86. doi: 10.3945/ajcn.113.068775. Epub 2013 Nov 27.
Reference Type
RESULT
Nilsson MI, Mikhail A, Lan L, Di Carlo A, Hamilton B, Barnard K, Hettinga BP, Hatcher E, Tarnopolsky MG, Nederveen JP, Bujak AL, May L, Tarnopolsky MA. A Five-Ingredient Nutritional Supplement and Home-Based Resistance Exercise Improve Lean Mass and Strength in Free-Living Elderly. Nutrients. 2020 Aug 10;12(8):2391. doi: 10.3390/nu12082391.
Reference Type
RESULT
Perez K, Ciotlos S, McGirr J, Limbad C, Doi R, Nederveen JP, Nilsson MI, Winer DA, Evans W, Tarnopolsky M, Campisi J, Melov S. Single nuclei profiling identifies cell specific markers of skeletal muscle aging, frailty, and senescence. Aging (Albany NY). 2022 Dec 13;14(23):9393-9422. doi: 10.18632/aging.204435. Epub 2022 Dec 13.
Reference Type
RESULT
Related Links
Access external resources that provide additional context or updates about the study.
http://pubmed.ncbi.nlm.nih.gov/32785021/
Pubmed link primary publication (Nilsson et al.)
https://pubmed.ncbi.nlm.nih.gov/36516485/
Pubmed link to aging biomarker publication (Perez et al.)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4656
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Combined Effects of Resistance Training and Nutritional Supplements in the Treatment of Sarcopenia
NCT00748696
TERMINATED
PHASE3
A Protein Supplementation and Exercise Strategy to Promote Muscle Protein Anabolism in Frail Elderly People
NCT01110369
COMPLETED
NA
The Effects of Resistance Training and Protein Supplementation in Healthy Elderly Men and Women.
NCT01004588
COMPLETED
NA
Protein Supplement and Exercise Training for the Treatment of Sarcopenia Risk in Older Adults
NCT05688956
RECRUITING
NA
Influence of Reduced Daily Step Count and Anabolic Interventions on Muscle Protein Metabolism in Older Persons
NCT02347137
COMPLETED
NA
Protein Supplementation and Mixed Power Training on Muscle Function and Functional Capacities in Elderly Men
NCT03393650
COMPLETED
NA
Effects of Resistance-band Training and Creatine and Whey Protein
NCT06606717
RECRUITING
NA
Nutrient Support to Body Composition and Healthy Ageing
NCT02529124
COMPLETED
NA
Intervention Assessing the Role of Exercise Program and Nutrition Supplement for Sarcopenia
NCT02374268
COMPLETED
NA
Multidisciplinary Research Into the Effects of Resistance Exercise and Whey Protein Supplementation in Healthy Older Men
NCT03299972
COMPLETED
NA
Sarcopenia Prevention With a Targeted Exercise and Protein Supplementation Program
NCT03417531
COMPLETED
NA
Leucine Co-ingestion and Myofibrillar Protein Synthesis in Older Adults
NCT02371278
COMPLETED
NA
Impact of Postprandial 'Exercise Snacks' on Protein and Glucose Metabolism Following a Period of Step Reduction in Older Adults
NCT05810272
UNKNOWN
NA
Effects of High-velocity Resistance Training and Creatine Supplementation in Healthy Aging Males
NCT03530202
UNKNOWN
PHASE2
the Effect of Exercise and Oral Supplement Intervention in Sarcopenia Markers in Hemodialysis Patients
NCT05809219
UNKNOWN
NA
Dietary Supplements and Aging Muscle
NCT01057082
COMPLETED
NA
Resistance Exercise Training and Amino Acid Leucine Supplementation in Frail Elderly Women
NCT01922167
COMPLETED
NA
Protein Intake and Step Reduction in Older Adults
NCT03285737
COMPLETED
NA
Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older Subjects.
NCT02090387
COMPLETED
NA
Leucine Supplementation Strategies to Enhance Muscle Anabolic Responses in Older Age
NCT06567665
RECRUITING
NA
Nutrition and Exercise for Sarcopenia
NCT00872911
COMPLETED
PHASE1
Effect of Exercise on the Human Skeletal Muscle Phosphoproteome
NCT04263714
COMPLETED
NA
Modulation of Muscle Protein Synthesis With Diet and Exercise in Old Aged Women
NCT02053441
COMPLETED
Exercise and Nutrition Interventions in Age-related Sarcopenia
NCT02912130
COMPLETED
NA
Protein Supplementation to Promote Muscle Protein Anabolism in Frail Elderly People
NCT01109628
COMPLETED
NA